baber/WOPTO huggingface dataset:
Patent ES-529358-A0 (ES)
IPC: B01D46/46
Filed: 1984-02-01
Abstract: The present invention relates to dust recovery apparatus comprising a housing capable of sustaining at least slight positive pressure and suitable for accommodating powder processing machinery, the housing having an inlet leading to a source of air and an outlet connected to an exhaust outlet via a collector for collecting air-intrained dust, means for passing air at a predetermined rate through the apparatus while maintaining a slight positive pressure in the housing and an air-flow rate sensor which detects air-flow rate in the apparatus and triggers means for stopping air passing to the collector when the air-flow rate falls outside a predetermined range.
Patent ES-550152-A0 (ES)
IPC: A61K39/385
Filed: 1985-12-19
Abstract: Covalently-modified neutral bacterial polysaccharides; covalent conjugates of such polysaccharides linked by a bigeneric spacer, with immunogenic bacterial membrane or other proteins, which conjugates are useful components of bacterial vaccines; and methods of preparing such polysaccharides and conjugates.
Patent FI-822639-A0 (FI)
Inventor: BOND ANTONY PHILIP
IPC: B01D33/04
Filed: 1982-07-28
Abstract: A vacuum filter belt (20) supporting a filter cloth (26) has transverse channels (34) leading to vacuum outlets (36). The belt is bounded by kerbs (38), each of which comprises a lower longitudinal region (42) which is longitudinally straight and curves smoothly into the top surface of the belt, and an upper longitudinal region (40) which is longitudinally sinusoidal, providing recesses (44) with surfaces (46) which slope downwardly towards the centre of the belt. The filter cloth (26) covers the belt and extends over the lower longitudinal region (42) and partway up the upper longitudinal region (40) of each kerb. The kerbs can flex as the belt passes around end rollers, and yet preserves a high filtering efficiency without requiring undue accuracy in tracking the filter cloth.
Patent FI-843873-A0 (FI)
Inventor: AHNSTROEM OVE
IPC: B21D5/14
Filed: 1984-10-02
Abstract: The present invention relates to rounded corrugated sheeting (4) whose profile exhibits crest portions (5), flanks (6), and bottom portions (7). The crest portions (5) are located on the concave side of the rounded sheet and are provided with grooves formed by pressing during rounding of the sheeting. The grooves form ribs (10) on the convex side of the sheet. In the rounding of the sheet, the material present in the crest-portions (5) of the sheet (4) is distributed in a manner which facilitates rounding and counteracts the formation of folds or wrinkles in the crest portions (5), and prevents other forms of damage.
Patent FI-853624-A0 (FI)
Inventor: WUEST HANS-HEINER
IPC: C07C69/14
Filed: 1985-09-20
Abstract: 1-substituted tetralins of the formula I   <IMAGE>   where n, R1, R2, R3, R4, R5 and R6 have the meanings stated in the description, and their preparation are described. The compounds are useful for the treatment of disorders.
Patent FI-861358-A0 (FI)
Inventor: ZEUTHEN JESPER
IPC: C12N5/10
Filed: 1986-03-27
Abstract: The concentration of glycated hemoglobin, HbA1c, in hemoglobin from diabetic patients is regarded as a useful means of assessing the adequacy of diabetes control. This invention provides a monoclonal antibody which, due to its specific binding of HbA1c, can be used for the determination of HbA1c in blood samples by such analytical methods as radioimmuno assay or enzyme-linked immunosorbent assay.
Patent FI-881378-A0 (FI)
Inventor: BENGTSSON ERIK ALVAR
IPC: C01B15/023
Filed: 1988-03-23
Abstract: A process for the production of hydrogen peroxide according to the anthraquinone process. According to the process certain alkyl substituted caprolactames are used as solvents, and particularly as solvents for anthrahydroquinones. The substituted caprolactames, which for example can be hexyl caprolactam and octyl caprolactam, give a very good solubility for anthrahydroquinones and also for anthraquinones. The compounds can be used as the sole solvent at the production of hydrogen peroxide or in combination with conventionally used solvents such as hydrocarbons.
Patent FI-891110-A0 (FI)
Inventor: KARINEN PERTTI
IPC: A23L33/24
Filed: 1989-03-08
Abstract: The invention concerns a procedure for producing cellulose-containing fine fibre meant for raw material in the foodstuff and animal feed industry, the cereal product being treated with an enzyme preparation, the treated product being homogenized and the cellulose-containing fine fibre being separated from the homogenized product.
Patent FI-892000-A0 (FI)
Inventor: GOENNER SIEGMAR
IPC: B27H1/00
Filed: 1989-04-27
Abstract: PCT No. PCT/EP88/00005 Sec. 371 Date Jun. 19, 1989 Sec. 102(e) Date Jun. 19, 1989 PCT Filed Jan. 5, 1988 PCT Pub. No. WO88/05371 PCT Pub. Date Jul. 28, 1988.Boards that have been separated by a chipless cutting method using an inclined blade, are twisted and, in most instances, this twist has to be corrected before boards that have been produced in this manner can be used. An apparatus in which a plurality of pairs of rollers are arranged in tandem withing a main frame is used to do this. Each pair of rollers can be pivotted about the longitudinal axis of the main frame relative to the proceding pair. This forms a board guide channel that extends in the longitudinal direction of the main frame and which is twisted approximately about the longitudinal axis of the main frame. The boards that are to be straightened pass through the board guide channel and are permanently deformed, which compensates for the twist that originally existed in the board.
Patent FI-901862-A0 (FI)
Inventor: ASCHWANDEN FELIX
IPC: G04G15/00
Filed: 1990-04-12
Abstract: Methods of and apparatus for processing television signals wherein the television signals include image-representative information and a plurality of segments of accompanying supplementary information including VPS program identification information and a teletext listing including program title information and program source information encoded during vertical blanking intervals wherein the VPS program identification information is decoded and the teletext listing, certain coded color display information and included program identification information are also decoded, the program identification information from VPS and teletext are compared and thereafter at least program title information is displayed upon identifying matching information.
Patent FI-920789-A0 (FI)
Inventor: THESENFITZ KLAUS
IPC: B07B1/22
Filed: 1992-02-24
Abstract: Sieve drum (2) for conditioning and classifying granular material, having a feed device (100) and inner annular sieve sections (NW32, NW25, NW10) in succession in the longitudinal direction of the drum. The mesh size of the annular sieve sections changes in such a manner that the section (NW10) with relatively small mesh size is the annular sieve section closest to the discharge (9) and the section (NW32) with the largest mesh size is the annular sieve section axially furthest removed from the discharge (9). Outer annular sieve sections (NW4, NW18) with different mesh sizes are arranged radially outside the inner annular sieve sections (NW10, NW25, NW32). The section (NW4) with the smallest mesh size is the annular sieve section axially closest to the discharge (9), section (NW18) with medium mesh size is axially furthest removed from the discharge (9). A catch region (4-10) for sieved material with a particle size between the smaller (NW10) and the smallest mesh size (NW4) is arranged axially between the outer annular sieve sections with the smallest and the medium mesh size (NW4, NW18). <IMAGE>
Patent FI-922786-A0 (FI)
Inventor: HAUBS MICHAEL
IPC: B32B7/02
Filed: 1992-06-16
Abstract: PCT No. PCT/EP90/02021 Sec. 371 Date Jul. 2, 1992 Sec. 102(e) Date Jul. 2, 1992 PCT Filed Nov. 26, 1990 PCT Pub. No. WO91/09669 PCT Pub. Date Jul. 11, 1991.Composite membrane, process for its production and its use A composite membrane for gas separation having a three-layer structure, constructed from A) a supporting membrane layer made of porous polymer, B) a nonporous, gas-permeable intermediate layer, C) a permselective layer of regularly arranged organic molecules having a layer thickness of 3 to 100 nm, the layers (A) and (C) enclosing the intermediate layer (B), wherein the permselective layer (C) is constructed from regularly arranged amphiphilic molecules which contain one or two alkyl chains each having 7 to 25 carbon atoms per polar hydrophilic group.
Patent FI-925608-A0 (FI)
Inventor: KESKINEN KARI I
IPC: C07C2/12
Filed: 1992-12-10
Abstract: The invention concerns a process and a system for oligomerization of olefins. According to the process, feedstock containing olefins from C3 to C20, or a mixture thereof, is introduced to a catalytic distillation reactor system comprising a distillation column (27) and at least one side reactor (31, 32), where the olefins of the feedstock are contacted with a catalyst (30) for manufacturing a product containing oligomers. According to the invention, a solid oligomerization catalyst such as a zeolite is used, and the olefins are contacted with the catalyst at a temperature sufficiently high to attain oligomerization. The present process is employed in the manufacture of, e.g., intermediate distillates and lubricants. By combining the reaction and distillation steps in a single system, the energy balance of the oligomerization process can be improved substantially.
Patent FI-933487-A0 (FI)
Inventor: LEHLE LUDWIG
IPC: C12N1/16
Filed: 1993-08-06
Abstract: Saccharomyces mutants with defects in N-glycosylation which are obtainable by [<3>H]-mannose suicide selection, introduction of one or more selective markers, selection of those strains which, after transformation with the plasmid YEpL/GOD, on cultivation under standard conditions secrete 10 mg/l GOD or more into the culture medium, are allelic to the ngd mutations contained in Saccharomyces cerevisiae DSM 7042, DSM 7338, DSM 7160 and/or 7340, and express proteins with a uniform carbohydrate structure.
Patent FI-935631-A0 (FI)
Inventor: STRAUBINGER WERNER
IPC: B41F9/10
Filed: 1993-12-15
Abstract: To reduce the stoppage times of a rotary intaglio printing machine and the amount of waste occurring, provision is made in a doctor blade arrangement, in which a doctor blade extending parallel to the axis of rotation of the forme cylinder (1) is pressed against the forme cylinder with the aid of a doctor blade beam (25) to scrape off the excess ink, for the doctor blade to be formed by a strip (20) which is so flexible that it can be wound and unwound around axes running transversely to its longitudinal direction, for the doctor blade strip to be mounted and guided on the doctor blade beam in such a way that it is displaceable counter to and in the longitudinal direction, for the length of the doctor blade strip to be far greater than the axial length of the forme cylinder, and for a winding device (28, 29) to be arranged in each case in the region of the axial ends of the forme cylinder for winding and unwinding the doctor blade strip. Using a drive device, the doctor blade strip can be displaced in the longitudinal direction during the printing operation, in which case it is unwound from the one winding device and wound onto the other winding device. <IMAGE>
Patent FI-940912-A0 (FI)
Inventor: HARDESTY BOYD
IPC: C12N15/10
Filed: 1994-02-25
Abstract: Synthetic tRNAs are produced from tRNACys(AAA), tRNASer(AAA), tRNAeAla(AAA), and tRNAiAla(AAA) genes. Polyuridylic acid-dependent syntheses of polypeptides were carried out in vitro on E. coli ribosomes using the synthetic tRNAs.
Patent FI-942757-A0 (FI)
Inventor: LYNUM STEINAR
IPC: H05H1/34
Filed: 1994-06-10
Abstract: PCT No. PCT/NO92/00195 Sec. 371 Date Dec. 29, 1994 Sec. 102(e) Date Dec. 29, 1994 PCT Filed Dec. 11, 1992 PCT Pub. No. WO93/12633 PCT Pub. Date Jun. 24, 1993.A plasma torch is designed for energy supply for example for chemical processes. The plasma torch comprises at least three solid tubular electrodes (1, 2 and 3) located coaxially inside one another. The electrodes (1, 2, 3) can be moved axially in relation to one another. They are preferably electrically insulated (5, 6, 7) from one another and have connections for electrical power (8, 9, 10). When three electrodes are used, the middle electrode (2) is used as an auxiliary electrode or ignition electrode. It is then coupled with one of the other electrodes (1). The distance to third electrode (3) is adapted to the working voltage in such a way that a jump spark is obtained when the working voltage is connected. During operation the auxiliary electrode (2) is withdrawn from the plasma zone thus preventing it from continuously forming the foot point of the arc.
Patent FI-943799-A0 (FI)
Inventor: KAWAI AKIYOSHI
IPC: C07C275/64
Filed: 1994-08-18
Abstract: PCT No. PCT/JP94/01349 Sec. 371 Date May 24, 1996 Sec. 102(e) Date May 24, 1996 PCT Filed Aug. 15, 1994 PCT Pub. No. WO95/05360 PCT Pub. Date Feb. 23, 1995The invention relates to compounds of the formula   <IMAGE>   and to pharmaceutically acceptable salts thereof, wherein R1 is hydrogen, fluoro, or chloro, and R2 is hydrogen or methyl. The above compounds are lipoxygenase inhibitors. The invention also relates to pharmaceutical compositions containing the above compounds, and to methods of treating inflammatory and allergic conditions by administering the above compounds.
Patent FI-950368-A0 (FI)
Inventor: BLOOM ROBERTA CHRISTINE
IPC: A61K8/73
Filed: 1995-01-27
Abstract: The present invention relates to pharmaceutical compositions for topical application comprising a safe and effective amount of a pharmaceutical active, from about 0.1% to about 10.0% of a high molecular weight cationic polymer, from about 0.05% to about 5% of a high HLB non-ionic surfactant, and from about 0.1% to about 25% of an alkoxylated ether. In further embodiments, these compositions also comprise from about 0.01% to about 5% of a low HLB non-ionic surfactant.
Patent FI-962559-A0 (FI)
Inventor: EHRLICH MARIKA
IPC: A61K31/565
Filed: 1996-06-19
Abstract: A method for hormonal contraception having a first hormonal component and a second hormonal component packaged separately in a packing unit and intended for short-term sequential administration, each of the hormonal components being composed of a plurality of daily hormone units separately packaged and individually removable in the packing unit. The first hormonal component contains almost exclusively an estrogen preparation as an active hormonal ingredient, effecting a disturbance of the follicle stimulation. The second hormonal component contains, in combination, an estrogen preparation and a progestogen preparation in a therapeutic amount sufficient for ovulation inhibition. The total number of daily hormone units is equal to the total number of days of the desired cycle, with the first hormonal component including 5 or 14 daily units and the second hormonal component including 23 or 14 daily units. The plurality of daily units of the first hormonal component is lower than the plurality of daily units of the second hormonal component, characterized by such an arrangement of the daily units in the packaging unit that the daily units of the second hormonal component are taken first and the daily units of the first hormonal component are taken thereafter. The daily units of the second hormonal component do not contain the combination of biologically produced estrogen and synthetic estrogen.
Patent FI-970600-A0 (FI)
Inventor: EGGLESTON PHILIP W
IPC: F15B15/14
Filed: 1997-02-12
Abstract: An actuator for fluid control valves with a reversible power module having a stationary inner member and a coaxially aligned movable outer member coupled to the valve flow control element and slidably movable on the inner member. A chamber is formed between respective ends of the members. Pneumatic pressure applied to the chamber drives the movable member to actuate the valve in a first direction. A spring returns the movable member in the second direction. A second chamber is defined within the inner member and pneumatic pressure applied to the second chamber drives the movable member with or without the spring.
Patent FI-972391-A0 (FI)
Inventor: FLOYD WILLIAM C
IPC: C08L61/32
Filed: 1997-06-05
Abstract: A resin composition useful as a binder is provided comprising the reaction product of an amine derivative chosen from melamine, glycolurile or their mixtures with a C1 to C8 dialkoxyethanal, the reaction product is then reacted with a polyol.
Patent FI-973241-A0 (FI)
Inventor: ADOUL JEAN-PIERRE
IPC: G10L19/125
Filed: 1997-08-06
Abstract: The present invention relates to a method and device for conducting a search in a codebook. This codebook consists of a set of pulse amplitude/position combinations each defining a number L of positions p and comprising both zero-amplitude pulses and non-zero-amplitude pulses assigned to respective positions p = 1, 2, ...L of the combination. Also, each non-zero-amplitude pulse assumes one of q possible amplitudes. According to the method, a subset of combinations is pre-selected from the codebook, and the search is limited to this subset to reduce complexity thereof. To pre-select the subset, an amplitude/position function is pre-established in relation to the sound signal. Pre-establishing the amplitude/position function includes pre-assigning one of the q possible amplitudes to each position p by (i) processing the sound signal to produce a backward-filtered target signal D and a pitch-removed residual signal R', (ii) calculating an amplitude estimate vector B in response to the signals D and R', and (iii) for each position p, quantizing an amplitude estimate Bp of the vector B to obtain the amplitude to be selected for that particular position p.
Patent FI-980742-A0 (FI)
Inventor: BAUMGAERTEL CHRISTOF
IPC: F16L9/12
Filed: 1998-04-01
Abstract: The thermoplastics pipe comprises an inner pipe of high density polyethylene with a long term strength of greater than 8 N/mm<2> and a cover layer of crosslinked polyethylene and has a total wall thickness and an internal pressure resistance identical with those of a single layer standard pipe of long term strength ≤ 8 N/mm<2>. Preferably, the cover layer contains an additive having a diffusion barrier effect, preferably 10-80 wt.% of a polyamide or 3-10 wt.% of metallic micro-lamellae.
Patent IL-61873-A0 (IL)
Title: 2,4,6-triiodoisophthalic acid derivatives,process for their preparation and x-ray contrast agents containing them
IPC: C07C233/65
Filed: 1981-01-07
Abstract: 1. Compounds of the general formula I   see diagramm : EP0032387,P17,F5   in which X represents the radical -CO.N.R1 R2 , -CCOR3 , -CH2 .NH.R7 or -CH2 OH, Y represents the radical -N.R1 R2 or -OR3 , Z represents the radical -N.R1 R2 , -NH.R7 , -NH.(sugar radical) or -OR3 , -N.R1 R2 in X, Y and Z being the same or different, R1 and R2 are the same or different and represent a hydrogen atom or a straight-chain or branched-chain alkyl radical having from 1 to 6 carbon atoms or a mono- or polyhydroxylated straight-chain or branched-chain alkyl radical having from 2 to 8 carbon atoms and from 1 to 5 hydroxy groups, R3 represents an alkyl radical having from 1 to 4 carbon atoms or a hydroxylated alkyl radical having from 2 to 4 carbon atoms and from 1 to 3 hydroxy groups, and R7 represents the acyl radical of an aliphatic carboxylic acid having from 2 to 5 carbon atoms which may optionally be substituted by from 1 to 5 hydroxy groups, it being possible for the hydroxy groups also to be functionally modified.
Patent IL-69368-A0 (IL)
Title: Fungicidal compositions and method for using them
IPC: A01N63/38
Filed: 1983-07-28
Abstract: A biological control agent comprising the antifungal agent Trichoderma harzianum T-35 (ATCC No. 20691), which is characterized by antifungal activity against fungi of the genus Fusarium. This strain is useful for protecting most crops affected by the fungus Fusarium spp. and is more active than other previously disclosed strains. Biocontrol compositions containing T. harzianum T-35 (ATCC No. 20691) provide antifungal protection to a broad spectrum of plants, including wheat, cotton, melons and tomatoes.
Patent IL-70356-A0 (IL)
Title: Antiinflammatory and antiallergic compounds,processes for the preparation thereof and pharmaceutical compositions containing the same
IPC: C07C217/56
Filed: 1983-12-01
Abstract: Compounds of the structure: <CHEM> and pharmaceutically acceptable salts thereof, wherein R1 and R2 are independently hydrogen, alkyl, carboxy, alkanoyloxy, aroyloxy, carboxyalkyl, carbalkoxyalkyl, carbalkoxy, alkanoyl, formyl, nitrile, amino, aminoalkyl, alkylamino, carboxamide, halo, trihalomethyl, hydroxy, aryloxy, nitro, sulfamyl, thio, alkylthio, and R1 and R2 when taken together with the carbon atoms to which they are attached form a phenyl ring;  Z is C or N; X is -O-, S-, @NR4, -CH2Z1-, -CH=N-, -CH=CH, -C IDENTICAL C-, @C=O, -CH2ZCH2-, -CH=CH- or ZC=O-; Y is -CHCH2-, -CH=CH-, -CHCHR5- or -CH[C(R5)3]2- when R3 is monovalent or -C-CH2- when R3 is O;  R3 is O, OH, OR4, SH, SR4, NH, HHR4 or N(R4)2; and  M is an integer from 0 to 10;  wherein Z1 is O, S or NR4; R4 is H, alkyl, pyranyl or aryl; and R5 is H, alkyl or fluoro.
Patent IL-71248-A0 (IL)
Title: Chlorthalidone dispersions,their preparation and pharmaceutical compositions containing them
IPC: A61K31/00
Filed: 1984-03-15
Abstract: Water-soluble dispersions of chlorthalidone are prepared by a process comprising: (a) forming a solution comprising a water soluble pharmaceutically acceptable polymeric carrier and a C1-C4 alkanol,  (b) dissolving chlorthalidone in the solution thus formed, and  (c) removing the C1-C4 alkanol from the solution by evaporation, the amount of said carrier being effective to suppress substantially the formation of the alkyl ether by-product from the reaction of chlorthalidone with the C1-C4 alkanol. A preferred water soluble carrier is polyvinylpyrrolidon and a preferred C1-C4 alkanol is methanol.
Patent IL-72018-A0 (IL)
Title: Biologically active peptides structurally related to regions within growth hormones
IPC: C07K7/06
Filed: 1984-06-04
Abstract: Disclosed are novel synthetic peptides having primary structural homology to a continuous sequence of amino acid residues of human growth hormone in a region spanning positions thirty-two to forty-six ("hGH<sub>32</sub>-<sub>46</sub>", or "deletion peptide"). In preferred forms, peptides of the invention comprehend: duplicate portions (i.e., sequence fragments) of hGH<sub>32-46</sub>; stereochemical analogs and fragment analogs of hGH<sub>32-46</sub> including one or more amino acid residues in D-isomeric configuration; and, "interspecies" analogs and fragment analogs of hGH<sub>32</sub>-<sub>46</sub> including one or more non-homologous amino acid residues duplicating variant residues present in corresponding positions in corresponding regions of heterologous species growth hormones. Peptides of the invention are administered to mammals contemporaneously with exogenous insulin to generate hypoglycemic effects greater than available through administration of insulin alone. A presently preferred heptapeptide has the sequence, NH<sub>2</sub>-Glu-Glu-Ala-Tyr-Ile-Pro-Lys-COOH, and has insulinpotentiating activity greater than hGH<sub>32</sub>-<sub>46</sub>.